These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 24055326)

  • 1. Observational research--opportunities and limitations.
    Boyko EJ
    J Diabetes Complications; 2013; 27(6):642-8. PubMed ID: 24055326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Future for Observational Epidemiology: Clarity, Credibility, Transparency.
    Harper S
    Am J Epidemiol; 2019 May; 188(5):840-845. PubMed ID: 30877294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accounting for Confounding in Observational Studies.
    D'Onofrio BM; Sjölander A; Lahey BB; Lichtenstein P; Öberg AS
    Annu Rev Clin Psychol; 2020 May; 16():25-48. PubMed ID: 32384000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Research Methodology 2: Observational Clinical Research.
    Sessler DI; Imrey PB
    Anesth Analg; 2015 Oct; 121(4):1043-1051. PubMed ID: 26378704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emulating an RCT in observational research in chest trauma: The target trial approach.
    Cocco AM; Jennings FL; Lockwood D
    J Trauma Acute Care Surg; 2021 Dec; 91(6):951-955. PubMed ID: 34369436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Two-Step Framework for Validating Causal Effect Estimates.
    Shen L; Visser E; van Erning F; Geleijnse G; Kaptein M
    Pharmacoepidemiol Drug Saf; 2024 Sep; 33(9):e5873. PubMed ID: 39252380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies.
    Schuler MS; Rose S
    Am J Epidemiol; 2017 Jan; 185(1):65-73. PubMed ID: 27941068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measured and accounted-for confounding in pharmacoepidemiologic studies: Some thoughts for practitioners.
    Roy J; Mitra N
    Pharmacoepidemiol Drug Saf; 2021 Mar; 30(3):277-282. PubMed ID: 33372303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities.
    Cameron C; Fireman B; Hutton B; Clifford T; Coyle D; Wells G; Dormuth CR; Platt R; Toh S
    Syst Rev; 2015 Nov; 4():147. PubMed ID: 26537988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causal inference in perioperative medicine observational research: part 2, advanced methods.
    Krishnamoorthy V; McLean D; Ohnuma T; Harris SK; Wong DJN; Wilson M; Moonesinghe R; Raghunathan K
    Br J Anaesth; 2020 Sep; 125(3):398-405. PubMed ID: 32527658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causal Methods for Observational Research: A Primer.
    Almasi-Hashiani A; Nedjat S; Mansournia MA
    Arch Iran Med; 2018 Apr; 21(4):164-169. PubMed ID: 29693407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication safety research by observational study design.
    Lao KS; Chui CS; Man KK; Lau WC; Chan EW; Wong IC
    Int J Clin Pharm; 2016 Jun; 38(3):676-84. PubMed ID: 27003827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Healthcare Research into Anti-VEGF Therapy: Selection and Methodological Precautions].
    Ziemssen F; Stahl A; Dimopoulos S
    Klin Monbl Augenheilkd; 2017 Dec; 234(12):1483-1492. PubMed ID: 28834972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causal inference with observational data: the need for triangulation of evidence.
    Hammerton G; Munafò MR
    Psychol Med; 2021 Mar; 51(4):563-578. PubMed ID: 33682654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing the issue of channeling bias in observational studies with propensity scores analysis.
    Lobo FS; Wagner S; Gross CR; Schommer JC
    Res Social Adm Pharm; 2006 Mar; 2(1):143-51. PubMed ID: 17138506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The limitations of observation studies for decision making regarding drugs efficacy and safety.
    Gueyffier F; Cucherat M
    Therapie; 2019 Apr; 74(2):181-185. PubMed ID: 30514576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agreement between study designs: a systematic review comparing observational studies and randomized trials of surgical treatments for necrotizing enterocolitis.
    van Heesewijk AE; Rush ML; Schmidt B; Kirpalani H; DeMauro SB
    J Matern Fetal Neonatal Med; 2020 Jun; 33(12):1965-1973. PubMed ID: 30554539
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision-making.
    Caparrotta TM; Dear JW; Colhoun HM; Webb DJ
    Br J Clin Pharmacol; 2019 Sep; 85(9):1907-1924. PubMed ID: 31206748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.